Efficacy of Plant Sterol-Fortified Dairy Product on Plasma Lipid and Plant Sterol Concentrations in Humans
NCT ID: NCT01478789
Last Updated: 2011-12-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47 participants
INTERVENTIONAL
2010-09-30
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Water dispersible Plant Sterol (WD-PS)
WD-PS dairy product (a novel formulation for dispersible free sterols in aqueous media produced)2g/d of free plant sterol
WD-PS intervention phase
2g/d of free plant sterol in 100g yogurt
Esterified plant sterol (PS-Ester)
PS-Ester enriched dairy product (2g/d free plant sterol)
PS-Ester intervention phase
2g/d of free plant sterol in 100g yogurt
placebo
100 g/d yogurt with no added plant sterol
placebo
100g/d yogurt with no added plant sterol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WD-PS intervention phase
2g/d of free plant sterol in 100g yogurt
PS-Ester intervention phase
2g/d of free plant sterol in 100g yogurt
placebo
100g/d yogurt with no added plant sterol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* plasma LDL-C levels \> 3.0mmol/l
* TG \< 4.5mmol/l
* body mass index (BMI) between 20 and 30 kg/m2.
Exclusion Criteria
* history of chronic use of alcohol (\>2 drinks/d)
* smoking
* myocardial infarction, coronary artery bypass, sitosterolaemia, kidney disease, liver disease or other major surgical procedures within the last six months
19 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Peter Jones
Director of the Richardson Centre for Functional Foods and Nutraceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Richarson Centre for Funtional Foods and Nutraceuticals
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2010:096
Identifier Type: -
Identifier Source: org_study_id